CCL2 and peripheral arterial disease: Our studies showed that patients with PAD had decreased serum PON1 activities and increased CCL2 concentrations [165,166,167], together with significant alterations in energy metabolism, including decreased circulating levels of branched-chain amino acids and increased levels of glutamate, glutamine, and several metabolites of the TCA cycle.